Alex J Eustace

Biography

Alex is an award winning translational oncology scientist who is a previous winner of the St Luke’s/ Royal Academy of Medicine Young Investigator award. His research into identification of novel targeted therapies has directly led to the initiation of early phase clinical trials in both melanoma patients and women with HER2-positive breast cancer in Ireland.  He has been published in high ranking journals such as Journal of the National Cancer Institute, Oncogene and Breast Cancer Research. He has a record of successfully gaining government and industrial funding to support his research. He is an ambitious, highly motivated, goal orientated research scientist.  Alex's current research goals are to determine the impact of kinase mutations on therapy response/resistance as a way of identifying novel therapeutic targets for the treatment of cancer. Alex is an award winning translational oncology scientist who is a previous winner of the St Luke’s/ Royal Academy of Medicine Young Investigator award. His research into identification of novel targeted therapies has directly led to the initiation of early phase clinical trials in both melanoma patients and women with HER2-positive breast cancer in Ireland.  He has been published in high ranking journals such as Journal of the National Cancer Institute, Oncogene and Breast Cancer Research. He has a record of successfully gaining government and industrial funding to support his research. He is an ambitious, highly motivated, goal orientated research scientist.  Alex's current research goals are to determine the impact of kinase mutations on therapy response/resistance as a way of identifying novel therapeutic targets for the treatment of cancer.

Research Interest

Molecular Biology, cell Biology, Business management